Answers are grounded in this paper and cite their sources.
Mechanisms of innate and adaptive immunity play a pivotal role in the development of cancer. Chronic inflammation can drive tumor development, but antitumor immunity can also restrict or even prevent tumor growth. New data show that feed-forward signals downstream of the receptor for advanced glycation end-products (RAGE) can fuel chronic inflammation, creating a microenvironment that is ideal for tumor formation.
No takes yet. Share an insight, caveat, or question.
Dougan et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: